Expression of human tumor-associated antigen RCAS1 in Reed-Sternberg cells in association with Epstein-Barr virus infection: A potential mechanism of immune evasion
Authors:
Open Access
- 6 April 2001
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 93 (1) , 91-96
Abstract
RCAS1 (receptor‐binding cancer antigen expressed on SiSo cells) is present in neoplastic cells, induces apoptosis of natural killer (NK)/T cells and plays a role in immune evasion. Fas ligand (FasL) is considered to have similar roles. The Epstein‐Barr virus (EBV)–encoded latent membrane protein is expressed by malignant Hodgkin and Reed‐Sternberg (H&RS) cells of EBV‐associated Hodgkin's disease (HD) and considered to be a target of cytotoxic T lymphocytes (CTLs). However, CTL response is inadequate in HD. To determine whether RCAS1 and FasL are expressed in EBV‐associated HD and participate in immune evasion, tissues of 20 EBV– and 15 EBV+ HD cases were immunohistochemically stained for RCAS1, FasL and HLA classes I and II, whose deficiencies could explain CTL escape. Lymphocytes surrounding H&RS cells tended to be CD4+ cells and rarely CD8+, TIA‐1+ (cytotoxic marker) or NK cells. HLA class I and/or II were expressed in all EBV+ HD cases, and RCAS1‐expressing H&RS cells were found in 14/15 (93%) EBV+ HD cases but only 8/20 (40%) EBV– HD cases (p < 0.05). FasL was detected in 9/15 (60%) and 7/20 (35%) EBV+ and EBV– HD cases, respectively. ssDNA‐positive (apoptotic) lymphocytes, surrounding H&RS cells, were rarely seen but were present in RCAS1+ cases (20/22 cases, 91%) rather than negative cases (0/13 cases, 0%) (p < 0.005). Our findings suggest that EBV+ H&RS cells might evade the host immune response by expressing RCAS1 rather than FasL.Keywords
This publication has 26 references indexed in Scilit:
- Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1Nature Medicine, 1999
- T cell defined tumor antigensCurrent Opinion in Immunology, 1997
- Serological identification of human tumor antigensCurrent Opinion in Immunology, 1997
- Lymphocyte apoptosis induced by CD95 (APO–1/Fas) ligand–expressing tumor cells — A mechanism of immune evasion?Nature Medicine, 1996
- A novel tumor-associated antigen expressed in human uterine and ovarian carcinomasCancer, 1996
- Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.Journal of Experimental Medicine, 1992
- Acute Infectious Mononucleosis: CD30 (Ki-1) Antigen Expression and Histologic CorrelationsAmerican Journal of Clinical Pathology, 1990
- A quantitative comparison of t-cell subsets in hodgkin's disease and reactive hyperplasia frozen section immunohistochemistryCancer, 1984
- Displacement of T Lymphocytes with the ‘Helper/Inducer’ Phenotype from Peripheral Blood to Lymphoid Organs in Untreated Patients with Hodgkin's DiseaseScandinavian Journal of Haematology, 1983
- In situ immunologic characterization of cellular constituents in lymph nodes and spleens involved by Hodgkin's diseaseBlood, 1982